Related Experiment Videos
[Current aspects of tumor immunology]
Zentralblatt Fur Gynakologie
|January 1, 1986
Summary
The exact cause of carcinomas remains unclear, but tumors correlate with immunological mechanisms. Tumor-associated antigens are important for monitoring cancer progression and recurrence, with monoclonal antibodies offering future therapeutic potential.
Area of Science:
- Oncology
- Immunology
Context:
- The etiology of carcinomas is not fully understood.
- Tumor-specific antigens require further demonstration.
- Carcinomas exhibit a strong correlation with immunological mechanisms.
Purpose:
- To explore the role of immunological mechanisms in carcinoma development.
- To highlight the significance of tumor-associated antigens as biomarkers.
- To assess the potential of immunotherapy and monoclonal antibodies in cancer treatment.
Summary:
- Immunophenomena are present in patients with malignant tumors (malignomas).
- Tumor-associated antigens serve as practical tumor markers for disease course and detecting carcinoma recurrence.
- Current immunotherapy for malignant tumors has limited success, suggesting a need for improved strategies.
Impact:
- Advances in understanding tumor-associated antigens can improve cancer diagnosis and prognosis.
- Monoclonal antibodies show promise for enhancing the efficacy of cancer immunotherapy.
- Further research into the immunological aspects of cancer is crucial for developing effective treatments.